Jazz Pharmaceuticals SG&A Expense (Quarterly) Trends

Jazz Pharmaceuticals PLC (JAZZ)

109.74 +0.91 (+0.84%) USD | NASDAQ | Apr 23, 16:00

109.64 -0.10 (-0.09%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
December 31, 2023	396.03M
September 30, 2023	308.31M
June 30, 2023	340.84M
March 31, 2023	297.92M
December 31, 2022	383.20M
September 30, 2022	358.48M
June 30, 2022	366.47M
March 31, 2022	308.81M
December 31, 2021	398.46M
September 30, 2021	363.68M
June 30, 2021	429.03M
March 31, 2021	260.51M
December 31, 2020	247.17M
September 30, 2020	207.26M
June 30, 2020	191.41M
March 31, 2020	208.40M
December 31, 2019	214.28M
September 30, 2019	178.71M
June 30, 2019	176.01M
March 31, 2019	167.95M
December 31, 2018	161.86M
September 30, 2018	155.87M
June 30, 2018	158.58M
March 31, 2018	207.21M
December 31, 2017	143.05M

Date	Value
September 30, 2017	124.52M
June 30, 2017	132.33M
March 31, 2017	144.26M
December 31, 2016	127.14M
September 30, 2016	124.37M
June 30, 2016	122.62M
March 31, 2016	128.76M
December 31, 2015	125.56M
September 30, 2015	104.04M
June 30, 2015	107.13M
March 31, 2015	112.39M
December 31, 2014	105.69M
September 30, 2014	93.50M
June 30, 2014	100.56M
March 31, 2014	106.36M
December 31, 2013	81.30M
September 30, 2013	74.97M
June 30, 2013	77.51M
March 31, 2013	70.53M
December 31, 2012	61.38M
September 30, 2012	60.92M
June 30, 2012	57.22M
March 31, 2012	44.36M
December 31, 2011	36.38M
September 30, 2011	30.55M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

176.01M

Minimum

Jun 2019

429.03M

Maximum

Jun 2021

296.58M

Average

308.31M

Median

Sep 2023

SG&A Expense (Quarterly) Benchmarks